Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years - Concepedia

Concepedia

Publication | Open Access

Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years

DOI Full Paper Access

154

Citations

21

References

2021

Year

Brandon Essink, Charu Sabharwal, Kevin Cannon, Robert W. Frenck, Himal Lal, Xia Xu, Vani Sundaraiyer, Yahong Peng, Lisa Moyer, Michael W. Pride,

Clinical Infectious Diseases

Abstract

NCT03760146.

References

	Year	Citations

Page 1